Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response

Without approved vaccines and specific treatments, COVID-19 is spreading around the world with above 26 million cases and approximately 864 thousand deaths until now. An efficacious and affordable vaccine is urgently needed. The Val308 – Gly548 of spike protein of SARS-CoV-2 linked with Gln830 – Glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Qiu-Dong, Zou, Ye-Ning, Yi, Yao, Shen, Li-Ping, Ye, Xiang-Zhong, Zhang, Yang, Wang, Hui, Ke, Hong, Song, Jing-Dong, Hu, Ke-Ping, Cheng, Bo-Lin, Qiu, Feng, Yu, Peng-Cheng, Zhou, Wen-Ting, Zhao, Ran, Cao, Lei, Dong, Gao-Feng, Bi, Sheng-Li, Wu, Gui-Zhen, Gao, George Fu, Zheng, Jerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816590/
https://www.ncbi.nlm.nih.gov/pubmed/33516600
http://dx.doi.org/10.1016/j.vaccine.2021.01.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816590/
https://www.ncbi.nlm.nih.gov/pubmed/33516600
http://dx.doi.org/10.1016/j.vaccine.2021.01.044

Ejemplares similares